As on Wednesday, Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) started slowly as it slid -12.58% to $1.32, before settling in for the price of $1.51 at the close. Taking a more long-term approach, BDRX posted a 52-week range of $0.67-$20.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 53.21%. Meanwhile, its Annual Earning per share during the time was 86.34%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 91.79%. This publicly-traded company’s shares outstanding now amounts to $2.97 million. The organization now has a market capitalization sitting at $0.32 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1423, while the 200-day Moving Average is $3.1616.
Biodexa Pharmaceuticals Plc ADR (BDRX) Earnings and Revenue Records
Biodexa Pharmaceuticals Plc ADR’s EPS increase for this current 12-month fiscal period is 91.79% and is forecasted to reach -0.00 in the upcoming year.
Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) Trading Performance Indicators
Let’s observe the current performance indicators for Biodexa Pharmaceuticals Plc ADR (BDRX). It’s Quick Ratio in the last reported quarter now stands at 1.26. The Stock has managed to achieve an average true range (ATR) of 0.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.67.
In the same vein, BDRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -19.22, a figure that is expected to reach -0.00 in the next quarter, and analysts are predicting that it will be -0.00 at the market close of one year from today.
Technical Analysis of Biodexa Pharmaceuticals Plc ADR (BDRX)
Through scrutinizing the latest numbers posted by the [Biodexa Pharmaceuticals Plc ADR, BDRX], it can be observed that its last 5-days Average volume of 15.31 million was better the volume of 2.49 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 66.36% While, its Average True Range was 0.2397.
Raw Stochastic average of Biodexa Pharmaceuticals Plc ADR (BDRX) in the period of the previous 100 days is set at 22.49%, which indicates a major fall in contrast to 60.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 270.32% that was higher than 175.63% volatility it exhibited in the past 100-days period.
